MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...
As a government project in a NATO member state and candidate for EU membership, the venture will benefit from exceptional terms for Israeli companies. Following the closer relations between Israel and ...
Abstract: This paper presents a pipelined SAR ADC with a two-stage closed-loop residue amplifier (RA). The proposed RA incorporates a floating gm-ratio-based amplifier (FGA) as the first stage and a ...
Abstract: Nowadays, SAR ADC is popular due to the high energy efficiency. However, in high-resolution applications, the power and area are too large as the kT/C-noise requirement leads to a huge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results